Lam Research Corporation $LRCX Shares Sold by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 15.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 83,307 shares of the semiconductor company’s stock after selling 14,934 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Lam Research were worth $14,260,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. PMV Capital Advisers LLC acquired a new position in shares of Lam Research during the 4th quarter worth about $25,000. Stance Capital LLC purchased a new position in shares of Lam Research in the 3rd quarter valued at about $26,000. Triumph Capital Management acquired a new stake in shares of Lam Research during the 3rd quarter worth about $27,000. Harbor Investment Advisory LLC lifted its stake in Lam Research by 73.9% during the fourth quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company’s stock worth $41,000 after purchasing an additional 102 shares during the last quarter. Finally, Howard Hughes Medical Institute purchased a new stake in Lam Research during the second quarter worth approximately $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is owned by company insiders.

Analysts Set New Price Targets

LRCX has been the topic of several recent analyst reports. Royal Bank Of Canada reiterated an “outperform” rating and issued a $290.00 price target (up from $260.00) on shares of Lam Research in a research note on Thursday, January 29th. Sanford C. Bernstein boosted their price objective on shares of Lam Research from $275.00 to $285.00 and gave the stock an “outperform” rating in a research report on Monday, February 9th. KeyCorp restated a “sector weight” rating on shares of Lam Research in a report on Thursday, January 29th. Evercore set a $275.00 target price on shares of Lam Research in a research report on Thursday, January 29th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $320.00 price target (up from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $245.35.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $211.41 on Friday. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $256.68. The stock has a 50 day moving average of $227.81 and a two-hundred day moving average of $181.88. The stock has a market cap of $264.00 billion, a P/E ratio of 43.32, a P/E/G ratio of 2.27 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period last year, the firm posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.